MARY CHANCE: Open Payments
NPI 1083190896 · KINGFISHER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 18 payments from 12 companies in 2025. Trend: 2023 $363 · 2024 $501 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| ABBVIE INC. | 3 | $45 |
| Astellas Pharma US Inc | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $29 |
| Globus Medical, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: Kerendia, Veozah, GVOKE HYPOPEN, UBRELVY, Senza, Qelbree, Auvelity, Ozempic.
Industry payments across OK — which companies pay providers there.
